RARRES2 and carcinoma: In wild-type mice, 28% of the papillomas progressed to large tumors (>3 mm) or carcinomas by the end of the protocol, and the absence of such tumors in the K5-chemerin group is highly significant (p < 0.001, Pearson's chi-square test).